XGN News and Press, Exagen Inc.

Uniquely identified ~25% of the SLE patients who would otherwise be missed by conventional markers Demonstrated superior diagnostic accuracy compared with conventional testing, supporting earlier, more definitive diagnosis Performed consistently across more than 1,200 SLE patients and 14 ...

2026-05-12 14:16:06 ET Image source: The Motley Fool. Monday, May 11, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-05-12 01:31:30 ET More on Exagen Exagen Inc. 2026 Q1 - Results - Earnings Call Presentation Exagen Inc. (XGN) Q1 2026 Earnings Call Transcript Exagen Inc. 2025 Q4 - Results - Earnings Call Presentation Exagen beats top-line and bottom-line estimates; rea...

2026-05-12 01:30:45 ET Exagen Inc. (XGN) Q1 2026 Earnings Call May 11, 2026 8:30 AM EDT Company Participants Tina Jacobsen - Vice President of Investor Relations John Aballi - CEO, President & Director Jeffrey Black - CFO & Corporate Secretary ... ...

2026-05-11 10:59:48 ET Denver, Colorado ( www.247marketnews.com ) – Momentum traders are once again crowding into emerging growth sectors as artificial intelligence infrastructure, defense modernization, advanced medical technologies, and digital asset finance combine to create o...

2026-05-11 08:08:07 ET More on Exagen Exagen Inc. 2025 Q4 - Results - Earnings Call Presentation Exagen Inc. (XGN) Q4 2025 Earnings Call Transcript Exagen outlines $70M–$73M 2026 revenue target while expanding sales force and innovation cadence Quant s...

CARLSBAD, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2026, and recent corporate updates. First Quarter 2026 Highlights: Achieved record total revenu...

CARLSBAD, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended March 31, 2026, before the market opens on Monday, May 11, 2026. John Aballi, President and Chief Executive Off...

2026-03-10 18:50:50 ET More on Exagen Exagen Inc. (XGN) Q4 2025 Earnings Call Transcript Quant snapshot: Avino Silver & Gold, Harmony Gold lead strong buys as Angel Studios, Exagen lag Seeking Alpha’s Quant Rating on Exagen Historical earnings data...

2026-03-10 18:50:17 ET Exagen Inc. (XGN) Q4 2025 Earnings Call March 10, 2026 8:30 AM EDT Company Participants Tina Jacobsen John Aballi - CEO, President & Director Jeffrey Black - CFO & Corporate Secretary ... Read the full article on Seeking Alp...